Literature DB >> 31389969

A non-intrusive evaluation method for tumor-targeting characteristics of nanomedicines based on in vivo near-infrared fluorescence imaging.

Hao Liu1, Rebecca T Marquez, Xiaoqing Wu, Ke Li, Shweta Vadlamani, Song Li, Ya Wang, Liang Xu, Daocheng Wu.   

Abstract

We developed a novel evaluation method for tumor-targeting characteristics of nanomedicines, average tumor-targeting index (average TTI) and "area under the tumor-targeting index-time curve" (AUTC) were established as the indicators for tumor targeting of nanomedicines based on NIR fluorescence imaging, which helps real-time monitoring of targeting ability and tumor changes in vivo without culling animals.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31389969      PMCID: PMC6686867          DOI: 10.1039/c9tb00882a

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  21 in total

Review 1.  The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.

Authors:  H Maeda
Journal:  Adv Enzyme Regul       Date:  2001

2.  Uptake and intracellular fate of polyethylenimine in vivo.

Authors:  M Lecocq; S Wattiaux-De Coninck; N Laurent; R Wattiaux; M Jadot
Journal:  Biochem Biophys Res Commun       Date:  2000-11-19       Impact factor: 3.575

3.  PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel.

Authors:  Yixian Huang; Jianqin Lu; Xiang Gao; Jiang Li; Wenchen Zhao; Ming Sun; Donna Beer Stolz; Raman Venkataramanan; Lisa Cencia Rohan; Song Li
Journal:  Bioconjug Chem       Date:  2012-06-20       Impact factor: 4.774

4.  Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting.

Authors:  Khaled Greish
Journal:  Methods Mol Biol       Date:  2010

5.  Peripheral-type benzodiazepine receptor levels correlate with the ability of human breast cancer MDA-MB-231 cell line to grow in SCID mice.

Authors:  M Hardwick; J Rone; Z Han; B Haddad; V Papadopoulos
Journal:  Int J Cancer       Date:  2001-11-01       Impact factor: 7.396

6.  In vivo imaging of siRNA delivery and silencing in tumors.

Authors:  Zdravka Medarova; Wellington Pham; Christian Farrar; Victoria Petkova; Anna Moore
Journal:  Nat Med       Date:  2007-02-25       Impact factor: 53.440

7.  Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.

Authors:  Meihua Yu; Siddharth Jambhrunkar; Peter Thorn; Jiezhong Chen; Wenyi Gu; Chengzhong Yu
Journal:  Nanoscale       Date:  2012-10-18       Impact factor: 7.790

8.  Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells.

Authors:  Claudio Surace; Silvia Arpicco; Amélie Dufaÿ-Wojcicki; Véronique Marsaud; Céline Bouclier; Denis Clay; Luigi Cattel; Jack-Michel Renoir; Elias Fattal
Journal:  Mol Pharm       Date:  2009 Jul-Aug       Impact factor: 4.939

9.  In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores.

Authors:  Kohei Sano; Makoto Mitsunaga; Takahito Nakajima; Peter L Choyke; Hisataka Kobayashi
Journal:  Breast Cancer Res       Date:  2012       Impact factor: 6.466

10.  A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studies.

Authors:  Sabrina Oliveira; Ruth Cohen; Marijke Stigter-van Walsum; Guus Ams van Dongen; Sjoerd G Elias; Paul J van Diest; Willem Mali; Paul Mp van Bergen En Henegouwen
Journal:  EJNMMI Res       Date:  2012-09-25       Impact factor: 3.138

View more
  1 in total

1.  Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect.

Authors:  Hao Liu; Ruirui Zhang; Dan Zhang; Chun Zhang; Zhuo Zhang; Xiujuan Fu; Yu Luo; Siwei Chen; Ailing Wu; Weiling Zeng; Kunyan Qu; Hao Zhang; Sijiao Wang; Houyin Shi
Journal:  Int J Nanomedicine       Date:  2022-01-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.